Pheochromocytoma and Paraganglioma (PCPG) Market to Reach US$670 Million by 2036 at 7.3% CAGR, Driven by Targeted and Radioligand Therapies

Neutral

AI Analysis

Summary

Market analysis projects the pheochromocytoma and paraganglioma market will reach US$670 million by 2036, growing at a 7.3% CAGR driven by targeted and radioligand therapies.

Financial Highlights

Revenue

US$670 million by 2036

Importance:2/10

Sentiment:

0.00

market_analysispheochromocytomaparagangliomaPCPGradioligand_therapiestargeted_therapies

Read the original article

Published by yahoo_finance on October 8, 2026 10:30 AM

Read Original